Odyssey Math Tuition Launches Secondary 2 Online Math Tuition Elearning Course in Singapore, Aiming to Become Singapore's Top Math Tuition Agency Offering Online Tuition

Nov 13, 2025

Odyssey Math Tuition launches a Secondary 2 online math tuition elearning course in Singapore, featuring a proprietary MOE-aligned curriculum covering 14 key topics to boost exam performance via videos, quizzes, and practice resources.

Singapore, November 13, 2025 -- Odyssey Math Tuition has introduced a new secondary 2 math tuition elearning course within its innovative online tuition platform. This standalone online math tuition program is tailored for secondary 2 students in Singapore, offering a comprehensive elearning system that aligns with the Ministry of Education (MOE) syllabus. As a prominent tuition centre in Singapore, Odyssey Math Tuition seeks to empower students through this flexible Singapore tuition option, enabling them to build on foundational knowledge and prepare for higher-level challenges.


The course expands Odyssey Math Tuition's range of tuition Singapore services, providing secondary 2 students with self-paced access to high-quality math tuition materials. Guided by Principal Tutor Mr. Justin Tan, who earned a double major in Math and Economics from the National University of Singapore with Distinction and brings over 13 years of teaching expertise, the program features a proprietary customized math curriculum. This curriculum complements the Singapore MOE's math syllabus by delivering enriched content, strategic insights, and extensive practice opportunities that extend beyond conventional learning methods.

Through the integration of this customized curriculum in the secondary 2 math tuition elearning course, Odyssey Math Tuition equips students with enhanced conceptual depth and analytical tools, which greatly increases their chances of achieving better results in school examinations and national tests. The online tuition agency focuses on addressing typical difficulties encountered by secondary 2 students, promoting a thorough grasp of topics and effective exam strategies that contribute to improved academic performance.


The secondary 2 online math tuition elearning course encompasses 14 key topics from the MOE syllabus, each delivered via elearning videos, question banks, quizzes, and practice worksheets. These elements assist students in Singapore with solving math exam questions proficiently, featuring detailed step-by-step instructions that highlight critical thinking and application. The elearning videos, produced uniquely for Odyssey Math Tuition, include vivid illustrations and practical scenarios to render complex notions more accessible, while the question banks supply diverse problems from introductory to challenging levels.

Commencing with Linear Graphs and Simultaneous Linear Equations, the course examines plotting graphs, solving systems of equations, and interpreting intersections. This topic delves into methods like substitution and elimination, essential for modeling real-world relationships. Odyssey Math Tuition's customized curriculum augments this by incorporating graphical software simulations in elearning videos, allowing students to visualize solutions dynamically. Such enhancements to the MOE syllabus help mitigate errors in equation handling, thereby boosting exam accuracy and confidence.

Following this, Linear Inequalities are addressed, covering representation on number lines, solving inequalities, and graphing solution sets. The online tuition platform includes interactive quizzes that test boundary conditions and compound inequalities. As part of tuition Singapore provisions, Odyssey Math Tuition's proprietary approach uses scenario-based question banks, such as budgeting constraints, to make inequalities relatable. This complementary method ensures students can apply inequalities effectively, leading to stronger performance in assessment sections involving constraints.

Expansion and Factorisation of Algebraic Expressions forms a core segment of the secondary 2 math tuition program. It involves expanding products, factorizing by grouping, and recognizing patterns. Elearning videos from Odyssey Math Tuition break down processes with mnemonic aids, emphasizing common factors and differences of squares. The tuition centre in Singapore supplements the MOE syllabus with additional factorization drills in question banks, targeting frequent exam pitfalls and enhancing algebraic fluency for better test outcomes.

The course also covers Expansion and Factorisation Using Special Algebraic Identities, focusing on identities like (a+b)^2 and perfect cubes. Students practice expanding and factorizing expressions using these formulas. Odyssey Math Tuition's online math tuition resources provide guided examples in elearning, linking identities to geometric proofs for deeper insight. This customized extension to the syllabus aids in quick recognition during exams, significantly improving solving speed and scores.

Quadratic Equations and Graphs are explored in detail, including solving by factorization, completing the square, and the quadratic formula, alongside graphing parabolas. The elearning system offers plotting tools and vertex analysis in videos. Odyssey Math Tuition, as an online tuition agency, incorporates real-life applications like projectile motion in its curriculum, complementing MOE content and preparing students for graphical interpretation questions, thus elevating their exam readiness.

Algebraic Fractions and Formulae involve simplifying fractions, adding/subtracting them, and manipulating formulae. Question banks feature multi-step problems to build proficiency. The math tuition elearning course uses step-by-step decompositions in videos, with Odyssey Math Tuition's tailored curriculum adding cross-multiplication strategies to streamline processes, fostering efficiency that translates to higher marks in algebraic manipulations.

Direct and Inverse Proportion teach relationships between variables, including graphs and word problems. Students learn to set up equations for proportional scenarios. Singapore tuition through Odyssey Math Tuition includes practical examples like speed-distance in elearning, enhancing the MOE syllabus with inverse proportion applications in physics, which sharpens problem-solving for exam contexts.

Congruence and Similarity cover criteria for congruent and similar figures, including scale factors and transformations. The secondary 2 math tuition program utilizes diagram-based quizzes to reinforce proofs. Odyssey Math Tuition's customized approach adds similarity in maps and models, providing students with visual question banks that improve geometric reasoning and exam performance.

Pythagoras’ Theorem is presented with proofs, applications in right-angled triangles, and 3D extensions. Elearning videos demonstrate derivations and converse theorems. The tuition agency in Singapore complements this with coordinate geometry integrations, offering practice that aligns with MOE while boosting spatial skills for better test results.

Trigonometric Ratios introduce sine, cosine, and tangent in right triangles, with angle calculations. The course includes elevation/depression problems in question banks. Odyssey Math Tuition's online tuition features calculator tutorials in videos, extending the syllabus with real-world surveying examples to enhance accuracy in trigonometric exam questions.

Volume and Surface Area of Pyramids, Cones, and Spheres focus on formulas, nets, and calculations. Students practice with composite shapes. The elearning platform provides 3D visualizations, and Odyssey Math Tuition's curriculum adds optimization problems, complementing MOE content to improve volumetric reasoning for examinations.

Probability of Single Events covers basic probability, sample spaces, and complementary events. Quizzes test experimental vs. theoretical probability. Tuition Singapore via Odyssey Math Tuition incorporates tree diagrams in its customized materials, aiding in complex probability setups and increasing chances of excelling in probabilistic assessments.

Statistical Diagrams involve constructing and interpreting bar charts, pie charts, and histograms. The secondary 2 math tuition elearning course includes data analysis exercises. Odyssey Math Tuition enhances this with software-generated diagrams in videos, providing tools for precise interpretation that support stronger exam responses.

Finally, Averages of Statistical Data teach mean, median, mode, and range, with grouped data calculations. Question banks feature real datasets from Singapore contexts. The online math tuition program's proprietary curriculum adds weighted averages, ensuring comprehensive preparation that aligns with MOE and elevates analytical skills for superior exam performance.

Available on Odyssey Math Tuition's 24/7 elearning platform, the secondary 2 math tuition course includes unlimited access and progress tracking features. The tuition agency in Singapore regularly updates materials, with AI personalization in development. This integrates seamlessly with onsite math tuition at the physical tuition centre, established in September 2025.

The introduction of this course highlights Odyssey Math Tuition's position as a forward-thinking online tuition agency, committed to advancing mathematics education in Singapore. By utilizing its customized curriculum, the program not only supports but elevates the MOE syllabus, offering students a significant advantage in examinations through in-depth topic coverage, engaging resources, and focused practice.

About the company: About Odyssey Math Tuition Founded in 2013 by Principal Tutor Mr. Justin Tan (NUS Double Major in Math & Economics, Distinction), Odyssey Math Tuition is Singapore’s fast-growing math-specialist tuition agency and tuition centre. Serving Secondary 1–4 and JC 1–2 students, OMT delivers small-group onsite classes plus an unlimited 24/7 e-learning portal powered by its proprietary MOE-aligned curriculum. With bite-sized videos, question banks, topical quizzes and progress dashboards, every student masters exam techniques at their own pace—affordably and without hidden fees.

Contact Info:
Name: Odyssey Math Tuition
Email: Send Email
Organization: Odyssey Math Tuition Pte. Ltd.
Address: 160 Changi Rd, #01-02 Hexacube, Singapore 419728
Phone: 85748255
Website: https://share.google/Ia1eSfUjurfBGa6Zu

Video URL: https://www.youtube.com/@odysseymathtuition

Release ID: 89175815

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.

More News

Why your health insurance is dropping GLP-1 coverage
Oct 15, 2026
Why your health insurance is dropping GLP-1 coverage

The promise of GLP-1 drugs has always depended on people being able to afford them. These drugs still cost hundreds of dollars per month if you’re paying cash, at which point access becomes a privilege: The higher-income executive who wants to trim a few pounds might be able to afford them either way, but the low-income worker who needs the drug to lose significant weight might not be able to afford them — unless their health insurance covers it. For a while, the trend lines for GLP-1 insurance coverage were positive. As of 2026, roughly two-thirds of private employer plans, which insure half of Americans, were covering GLP-1 medications for weight loss to treat obesity. Over the summer, Medicare launched a new $50-per-month prescription program. The US has struggled with an obesity epidemic for decades, but it looked like powerful drugs to treat it were finally starting to be more seamlessly integrated into the health system. At least that’s how things appeared earlier this year. But now, private plans are pulling back from GLP-1 coverage. People are being left in the lurch, debating whether to try to pay for these drugs on their own or stop taking medicines they feel are making a real difference for their health. The dilemma reveals one of the structural flaws in American healthcare. For working-age adults, your insurance depends on your job. Unfortunately, because people no longer stay at the same job for decades, there is not a strong financial incentive for employers to make investments that will benefit your health in the long term — but there is a strong incentive to minimize short-term costs as much as possible. It’s the kind of perverse rationale that could compel employer-sponsored health plans to stop covering a drug that, if taken over the full course of a person’s life, could help them not only lose weight but ultimately reduce their risk of heart disease, kidney disease and other chronic health problems, improving their health and saving all of us money as they get older. “An employer or an insurer making coverage decisions doesn’t necessarily care if they’re saving Medicare money,” said Dan Sacks, a healthcare economist at the University of Wisconsin-Madison. “That’s a classic problem with the American health insurance system, and it’s certainly salient here.” This mismatch between what’s good for people’s health and what’s good for the corporate bottom line has long been one of the underlying flaws in the US health system. Now access to GLP-1 drugs is shrinking just as these drugs were starting to make a real dent in the US obesity crisis. The stakes couldn’t be higher. Why employer-sponsored health plans are suddenly dropping GLP-1 coverage From the beginning, insurance coverage was the big question hanging over GLP-1s and their potential to revolutionize US healthcare. But recently, it looked like we’d turned a corner. When I attended the Aspen Ideas: Health festival this summer, pharmaceutical reps seemed visibly relieved that GLP-1 coverage had been picking up among private insurers. In 2026, about two out of every three employer-sponsored plans were covering some of these drugs for weight management, up from about 20 percent just the year before. “They’re recognizing that this is an investment in their workforce,” said Laura Steele, who leads the cardiometabolic health unit at Eli Lilly, which manufactures Zepbound and Foundayo. “Yes, there is a budget, and there is a benefit design that every employer has. That’s real. That’s not going away. But they’re also recognizing the overall cost that they’re experiencing by not dealing with this too.” But as employers and private insurers make coverage decisions for next year, they are suddenly pulling back. At least 10 percent of employer plans that currently cover GLP-1s for weight loss say they are likely to discontinue coverage in 2027, according to one survey by the Business Group on Health — and that number may still increase. A Mercer survey of large employers found that 6 percent had dropped coverage in 2026 and another 5 percent were planning to in 2027 or actively considering it. A separate report from the Health Policy Commission in Massachusetts found that the number of commercially insured people in the state taking a GLP-1 drug had fallen by 50 percent between 2025 and the first quarter of 2026 as private coverage started to drop off.  Some of the biggest brands in the US are reportedly eliminating or reducing their coverage: PepsiCo, Starbucks, and Lowe’s among them. And their reasons are simple: It’s too expensive. The drugs still carry a high net price tag — $600 or more for a 30-day supply — and potential demand is high (2 in every 5 American adults have obesity).  When a lot of people start taking an expensive medication all at once, it’s going to raise costs for employer insurance plans — and they have to figure out how to adapt. Insurers set premiums at the start of each year, based on how many people are on the plan and how much healthcare they are expected to need. But if those estimates are off — say, if more people take an expensive GLP-1 drug than the insurer expected — they have to offset those costs somehow, and raising premiums the following year is a common solution. According to one estimate, premiums are projected to grow by 5 to 13 percent due to GLP-1 costs — and the burden of paying those higher premiums is likely to fall on the workers. The employer can also try to limit GLP-1 use by, for example, asking workers to pay more out of pocket for these drugs; according to Mercer, 27 percent of large US employers instituted some kind of utilization controls for GLP-1 drugs over the past year or plan to next year. They also have the option to simply stop covering these drugs for weight loss altogether — and that’s the route more and more of them are deciding to take. The abrupt reversal has even caught economists like Sacks off guard. 3 big reasons employer health plans are dropping GLP-1 coverage Employers aren’t invested in people’s long-term health: As Americans switch jobs more often, companies want to cut short-term costs. GLP-1 prices are still high, upwards of $600 per month per person for insurers. A lot of people are eligible to take them for weight loss; 2 in 5 US adults have obesity. “I was surprised that anyone would do an about-face because I thought they understood the trade-offs well,” Sacks said. “My guess is that it turned out to be more expensive than they anticipated: take-up is higher, and possibly more people are sticking with it. That’s one reason that you might not want to continue to offer it.” For employers, the short-term costs of covering a drug often outweigh the long-term benefits that medication may confer, at least from the employer’s POV. One analysis — notably produced by Blue Cross Blue Shield Kansas — concluded that covering GLP-1s for weight loss increased average employee health costs by $7,000 in the first year and another $4,200 in the second, largely due to the cost of the drugs themselves. And yet at the same time, there were no decreases in obesity-related medical events in that time period. Another study from Sacks and his colleagues at Indiana University and the University of South Carolina found that GLP-1 use did not lead to any cost savings over five years. So in the short term, these employers are arguably making an economically rational decision — but one that may still come at their employees’ expense. “I’m completely screwed,” said one person on Reddit about Cigna’s plans to drop GLP-1 coverage for their own employees. They’re looking at at least $300 for one month’s supply at cash prices.  They weren’t alone either: “I’m devastated,” said another person, commenting on Starbucks’s decision to stop covering GLP-1 drugs. They said they had an autoimmune condition that had made it difficult to lose weight — until this new class of medicines came along. Where GLP-1 coverage goes from here How could we end up here, where it makes good business sense for companies to make a decision that could potentially harm their workers’ health in the long term? It is at least in part a result of the haphazard way the US has ended up insuring people. When employer-sponsored insurance started to arise in the mid-20th century, eventually becoming the primary way to cover the working-age population, people tended to stay at the same job for a long period of time. In theory, there was a synergy: Companies wanted their workers to stay productive, and so it was worth it for the company to invest in their long-term health via their insurance benefits. And research has found that people who stay with the same company — and the same insurance plan — tend to have better health than those who switch a lot. But these days, people change jobs all the time or work various gigs to piece together an income. You probably don’t expect to stay at your job for 10 years — and your employer doesn’t expect you to either. Instead, they want to keep their own costs as low as possible in the short term. This leads them to cut GLP-1 coverage, even though doctors do believe that people could benefit tremendously long term from the weight loss these drugs help them achieve and all of its potential health benefits.  “There are very real health benefits of these drugs,” Sacks told me. “The fact that we don’t find offsets or they’re even more expensive than we thought doesn’t necessarily mean that we shouldn’t cover them.” Sign up for the Good Medicine newsletter Our political wellness landscape has shifted: new leaders, shady science, contradictory advice, broken trust, and overwhelming systems. How is anyone supposed to make sense of it all? Vox’s senior correspondent Dylan Scott has been on the health beat for a long time, and every week, he’ll wade into sticky debates, answer fair questions, and contextualize what’s happening in American healthcare policy. Sign up here. In theory, the market is supposed to fix the

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Expert Features

The Expert Features reports on the issues and the world’s everyday news. Handled by experts in different niches, you will find different subjects and perspectives.